Program - KSMO Conference

Plenary Lecture 1 Mechanisms of resistance to endocrine therapy in ER+ breast cancer

Carlos Arteaga UT Southwestern Medical Center USA CV
Plenary Lecture 2 Genomic diversity and molecular mechanisms driving cancer evolution

Charles Swanton Francis Crick Institute UK CV
Plenary Lecture 3 SCRUM-MONSTAR & CIRCULATE
-Japan platform to accelerate precision oncology innovations; achievement and perspective

Takayuki Yoshino The National Cancer Center Hospital East (NCCE) in Chiba Japan CV
Plenary Lecture 4 The past & future journey of cancer immunotherapy

Roy S. Herbst Yale School of Medicine USA CV

Scientific Symposium 1 T cells need our help to fight cancer, beyond PD-1/PD-L1 inhibitors

Omid Hamid The Angeles Clinic and Research Institute USA CV
Eui-Cheol Shin KAIST Graduate School
of Medical Science and Engineering Republic of Korea CV
Luis Alvarez-Vallina Cancer Immunotherapy Unit (UNICA) Spain CV
Prasad S. Adusumilli Memorial Sloan Kettering Cancer Center USA CV

Scientific Symposium 2 The next step in the treatment of GU cancers

Scientific Symposium 3 Treatment for NSCLC: The earlier, the better?

Scientific Symposium 4 Advance of perioperative chemotherapy in resectable or potentially resectable GI cancer

Scientific Symposium 5 Advances in genomics technology and its clinical adaptation

Maximilian Diehn Stanford University USA CV
Young Seok Ju KAIST Graduate School of Medical Science and Engineering / Genome Insight Inc. Republic of Korea CV
Hae-Ock Lee College of Medicine, The Catholic University of Korea Republic of Korea CV
Abhishek Jha Elucidata USA CV

Scientific Symposium 6 Artificial intelligence-empowered precision medicine in oncology: Cancer diagnosis, biomarker development, and drug discovery

Scientific Symposium 7 The blueprint for next-generation therapeutics

Xin Gao Massachusetts General Hospital USA CV
Ecaterina Elena Dumbrava The University of Texas, MD Anderson Cancer Center USA CV
Chul-Woong Chung LegoChem Biosciences, Inc. Republic of Korea CV
Elisabetta Leo Bioscience, Oncology R&D, AstraZeneca UK CV

Scientific Symposium 8 Recent strategies in treatment advances for metastatic GI cancers

Scientific Symposium 9 Recent advances in breast cancer treatment

Soo Chin Lee Cancer Science Institute of Singapore, National University of Singapore (NUS) Singapore CV
Barbara Pistilli Gustave Roussy France CV
Andrei Goga University of California San Francisco USA CV
Kyong-hwa Park Korea University Anam Hospital Republic of Korea CV

ASCO/KSMO Joint Symposium 1 Targeting rare genomic aberrations in precision oncology

Joint Symposium 2 (KSP/KSMO) Location matters: How spatial data is driving precision medicine

Alexander Swarbrick Garvan Institute of Medical Research, UNSW Sydney Australia CV
Jungmin Choi Korea University College of Medicine Republic of Korea CV
Minsun Jung Yonsei University College of Medicine Republic of Korea CV
Lucy Yates Wellcome Sanger Institute UK CV

Joint Symposium 3 (KCSG/KSMO) The near future of precision medicine - One more step

Joint Symposium 4 (KOSRO/KSMO) Advances in non-operative, organ-preserving strategy

Joint Symposium 5 (ESMO/KSMO) Multiomics approach for precision medicine

Benedikt Westphalen University of Munich Germany CV
Rodrigo Dienstmann Vall d'Hebron Institute of Oncology (VHIO) Spain CV
Se-Hoon Lee Samsung Medical Center Republic of Korea CV
Jangho Cho The Catholic University of Korea Incheon St. Mary's Hospital Republic of Korea CV

Joint Symposium 6 (ASCO/KSMO) Recent updates in multimodality cancer treatment

Joint Symposium 7 (JSMO/KSMO) Emerging Immuno-Oncology Strategy in Solid Tumors

Yasutoshi Kuboki National Cancer Center Japan Japan CV
Shigehisa Kitano Cancer Institute Hospital of JFCR Japan CV
Moon Ki Choi National Cancer Center Republic of Korea CV
In-Ho Kim The Catholic University of Korea Seoul St. Mary's Hospital Republic of Korea CV

Joint Symposium 8 (KSR/KSMO) Integrating interventional techniques in the immunotherapy landscape: Novel insights from radiology and oncology

Joint Symposium 9 (ESMO/KSMO) Immunooncology: Holistic perspectives for oncologists

Joint Symposium 10 (KSSO/KSMO) Hereditary cancer - Diagnosis & proper management

FACO Session 1 Recent updates in colorectal cancer treatment

Ying Yuan The Second Affiliated Hospital Zhejiang University School of Medicine China CV
Eiji Oki Kyushu University Japan CV

FACO Session 2 Proposals for new FACO clinical trials

Sehhoon Park Samsung Medical Center Republic of Korea CV
Ning Li Cancer Hospital Chinese Academy of Medical Sciences China CV
Keiichi Fujiwara Saitama Medical University International Medical Center Japan CV